Development of a Peptide-Based Nano-Sized Cathepsin B Inhibitor for Anticancer Therapy

Numerous cathepsin B inhibitors have been developed and are under investigation as potential cancer treatments. They have been evaluated for their ability to inhibit cathepsin B activity and reduce tumor growth. However, they have shown critical limitations, including low anticancer efficacy and hig...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, So-Hyeon, Lee, Jun-Hyuck, Yang, Seong-Bin, Lee, Dong-Nyeong, Kang, Tae-Bong, Park, Jooho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141979/
https://www.ncbi.nlm.nih.gov/pubmed/37111617
http://dx.doi.org/10.3390/pharmaceutics15041131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141979/
https://www.ncbi.nlm.nih.gov/pubmed/37111617
http://dx.doi.org/10.3390/pharmaceutics15041131

Ejemplares similares